[{"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00263.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0010\"></a><span class=\"fignum\">Fig. 12.1</span> <a class=\"calibre5\" id=\"sp0010\"></a>Clinical features of dementia.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0015\"></a>This figure shows some of the common features of dementia that are caused by degenerative changes in different parts of the cerebral cortex (frontal lobe = red, parietal lobe = blue, temporal lobe = yellow). The clinical picture in a particular person depends upon the distribution and severity of the changes.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00264.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0015\"></a><span class=\"fignum\">Fig. 12.2</span> <a class=\"calibre5\" id=\"sp0020\"></a>Distribution of IQ scores in the general population.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0025\"></a>Intelligence in the general population has a normal distribution, meaning that scores fall on a symmetrical bell curve. The mean IQ is 100 and the standard deviation is 15, such that 95% of scores fall between 70 and 130.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0020\"></a><span class=\"fignum\">Fig. 12.3</span> <a class=\"calibre5\" id=\"sp0030\"></a>Reduced hippocampal blood flow in early Alzheimer's disease.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0035\"></a>These images were obtained via single photon emission computer tomography (SPECT) scanning using a radioactive tracer and show regional cerebral blood flow. The upper image is a normal control subject and the lower image is from a patient with early Alzheimer's disease. The sections are in the axial (horizontal) plane and pass through the temporal lobe. The black box shows the position of the hippocampus in the medial temporal lobe. <span class=\"figcredit\">From Rodriguez, G. et\u202fal.: Hippocampal perfusion in mild Alzheimer's disease. Psychiatry Research: Neuroimaging (2000, pp. 65\u201374) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0025\"></a><span class=\"fignum\">Fig. 12.4</span> <a class=\"calibre5\" id=\"sp0040\"></a>Neuroimaging showing progressive brain atrophy in Alzheimer's disease (AD) in comparison to an age-matched control.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0045\"></a>These are fluid-registered volumetric MRI scans from a 60-year-old patient with Alzheimer\u2019s disease [right] and a normal age-matched control [left]. In each case, two MRI scans were acquired one year apart and have been registered together. Regions of brain loss are shown as blue-green; increases in CSF spaces are shown as red-yellow. In the patient with Alzheimer's disease, there is marked volume loss in the hippocampi and temporal lobes, with widespread symmetrical atrophy in other parts of the cerebral hemispheres and dilation of the ventricles. The control shows normal age-related atrophy. <span class=\"figcredit\">Courtesy of Professor Nick Fox.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0030\"></a><span class=\"fignum\">Fig. 12.5</span> <a class=\"calibre5\" id=\"sp0050\"></a>Cortical plaques in Alzheimer's disease.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0055\"></a>This micrograph demonstrates extensive amyloid beta deposits (amyloid plaques) in the cerebral cortex of a person who died of Alzheimer's disease. <em class=\"calibre10\">Inset</em>: a single \u2018cored plaque\u2019 with a dense central core of amyloid is shown at higher magnification [immunohistochemical preparation for A\u03b2 peptide].</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00266.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0035\"></a><span class=\"fignum\">Fig. 12.6</span> <a class=\"calibre5\" id=\"sp0060\"></a>Neurofibrillary tangles in Alzheimer's disease.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0065\"></a>Micrograph showing two cortical neurons containing neurofibrillary tangles. The small, rounded inclusion (right) is a \u2018globose\u2019 tangle whilst the larger, more pyramidal-shaped inclusion (left) is a \u2018flame\u2019 tangle. The different appearances of the pathological inclusions reflect the shape of the neuronal cell body, which is filled with abnormal tau protein. A few fine \u2018neuropil threads\u2019 can also be seen, representing neuronal processes filled with tau [immunohistochemistry for hyperphosphorylated tau protein].</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00267.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0040\"></a><span class=\"fignum\">Fig. 12.7</span> <a class=\"calibre5\" id=\"sp0070\"></a>Paired helical filament (PHF) tau forms neuronal inclusions in Alzheimer's disease and other neurodegenerative conditions.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0075\"></a><strong class=\"calibre8\">(A)</strong> Illustration showing the twisted structure of PHF-tau, which has a diameter of 22\u202fnm and a periodicity of 80\u202fnm; <strong class=\"calibre8\">(B)</strong> An electron micrograph showing paired helical filament tau. <span class=\"figcredit\">From Ellison and Love: Neuropathology 2e (Mosby 2003) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0045\"></a><span class=\"fignum\">Fig. 12.8</span> <a class=\"calibre5\" id=\"sp0080\"></a>Amyloid precursor protein (APP).<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0085\"></a><strong class=\"calibre8\">(A)</strong> The sequence corresponding to the amyloid beta peptide (A\u03b2) is shown in red, partially embedded in the neuronal plasma membrane; <strong class=\"calibre8\">(B)</strong> A closer view, showing the sites of action of the main APP processing enzymes. Gamma-secretase is a multi-subunit integral membrane protein that includes the enzymes presenilin-1 and presenilin-2 (PS1/PS2).</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00268.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0050\"></a><span class=\"fignum\">Fig. 12.9</span> <a class=\"calibre5\" id=\"sp0090\"></a>Processing of amyloid precursor protein.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0095\"></a><strong class=\"calibre8\">(A)</strong> The primary (alpha) pathway involves sequential cleavage by alpha and gamma secretases, which destroys the pathogenic (A\u03b2) fragment and is therefore non-amyloidogenic; <strong class=\"calibre8\">(B)</strong> The alternative (beta) pathway involves sequential cleavage by beta and gamma secretases, which releases the pathogenic A\u03b2 species. The alternative pathway is therefore potentially amyloidogenic.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0055\"></a><span class=\"fignum\">Fig. 12.10</span> <a class=\"calibre5\" id=\"sp0100\"></a>Tau is a microtubule-associated protein (MAP) that is normally found predominantly in axons.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0105\"></a><strong class=\"calibre8\">(A)</strong> In its unphosphorylated state, tau binds to microtubules and helps to stabilize them. Phosphorylation is regulated by the activity of kinases (which add phosphate groups) and phosphatases (which remove them); <strong class=\"calibre8\">(B)</strong> Hyperphosphorylated tau monomers dissociate from microtubules and, at sufficient concentrations, tend to self-aggregate to form paired helical filament tau (the main constituent of neurofibrillary tangles).</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00269.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0060\"></a><span class=\"fignum\">Fig. 12.11</span> <a class=\"calibre5\" id=\"sp0110\"></a>Progression of tangle pathology in Alzheimer's disease.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0115\"></a><strong class=\"calibre8\">(A)</strong> Coronal section through the temporal lobe showing the distribution of tangle pathology in early (Braak I\u2013II) Alzheimer's disease. The earliest and most severely affected area (between the dashed lines) is the transentorhinal cortex; <strong class=\"calibre8\">(B)</strong> Progression of tangle pathology in the intermediate (Braak III\u2013IV) and late (Braak V\u2013VI) stages.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00270.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0065\"></a><span class=\"fignum\">Fig. 12.12</span> <a class=\"calibre5\" id=\"sp0120\"></a>The concept of cognitive reserve.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0125\"></a>Individuals of average intelligence (red line) may show clinical signs of dementia much earlier after disease onset than people with a higher degree of premorbid intelligence or education (purple line), assuming that the rate of progression is similar.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00271.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0070\"></a><span class=\"fignum\">Fig. 12.13</span> <a class=\"calibre5\" id=\"sp0130\"></a>Functional neuroimaging in dementia with Lewy bodies (DLB).<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0135\"></a>Functional brain imaging in patients with DLB may show reduced glucose consumption (metabolism) in the occipital and posterior temporoparietal regions, as in this case. [The image was obtained by positron-emission tomography (PET) scanning, using <sup class=\"calibre14\">18</sup>F-FDG, a positron-emitting isotope of glucose]. <span class=\"figcredit\">From Silverman, D et\u202fal: Positron emission tomography scans obtained for the evaluation of cognitive dysfunction. Seminars in Nuclear Medicine. Neuronuclear Imaging (2008, pp. 251\u2013261) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00272.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0075\"></a><span class=\"fignum\">Fig. 12.14</span> <a class=\"calibre5\" id=\"sp0140\"></a>Lewy bodies and Lewy neurites.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0145\"></a><strong class=\"calibre8\">(A)</strong> This is a routine haematoxylin and eosin (H&amp;E)-stained section from the substantia nigra of a patient who had dementia with Lewy bodies (DLB). It shows a bright pink Lewy body in the neuronal cytoplasm, surrounded by brown neuromelanin pigment; <strong class=\"calibre8\">(B)</strong> Lewy bodies can be demonstrated using immunohistochemistry (antibody labelling) for alpha-synuclein, which is the main protein constituent; <strong class=\"calibre8\">(C)</strong> Cortical Lewy bodies are best detected by immunostaining for alpha-synuclein, in this case in the temporal lobe of a patient with DLB; <strong class=\"calibre8\">(D)</strong> Immunohistochemistry for alpha-synuclein in a patient with Alzheimer's disease showing co-existing Lewy bodies and Lewy neurites in the temporal lobe. From Popescu, A and Lippa, CF: Parkinsonian syndromes: Parkinson's disease dementia, dementia with Lewy bodies and progressive supranuclear palsy. <span class=\"figcredit\">Clinical Neuroscience Research, Non-Alzheimer's Disease Dementias (2004, pp. 461\u2013468) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00273.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0080\"></a><span class=\"fignum\">Fig. 12.15</span> <a class=\"calibre5\" id=\"sp0150\"></a>Progression of Lewy body pathology. <span class=\"figcredit\">From Basbaum, A: The senses: a comprehensive reference (Academic Press 2008) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0085\"></a><span class=\"fignum\">Fig. 12.16</span> <a class=\"calibre5\" id=\"sp0155\"></a>The risk factors for vascular dementia are the same as those for ischaemic heart disease.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00274.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0090\"></a><span class=\"fignum\">Fig. 12.17</span> <a class=\"calibre5\" id=\"sp0160\"></a>Multi-infarct dementia.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0165\"></a>Progression is classically said to occur in a step-wise fashion consistent with a series of small strokes, in contrast to the gradual decline seen in Alzheimer's disease.</figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00275.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0095\"></a><span class=\"fignum\">Fig. 12.18</span> <a class=\"calibre5\" id=\"sp0170\"></a>Axial MRI scan showing the typical imaging features of cerebral small vessel disease.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0175\"></a>There is confluent hyperintensity in the periventricular white matter and patches of hyperintensity in the deep and subcortical white matter. Additionally, there are several small focal cavities (with the same signal intensity as CSF) which are typical of \u2018old\u2019 lacunar infarcts [T2-weighted MRI with CSF suppression: fluid-attenuation inversion recovery or \u2018FLAIR\u2019 sequence]. <span class=\"figcredit\">Courtesy of Dr Andrew MacKinnon.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00276.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0105\"></a><span class=\"fignum\">Fig. 12.19</span> <a class=\"calibre5\" id=\"sp0180\"></a>Pathological features of small vessel disease.<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0185\"></a><strong class=\"calibre8\">(A)</strong> Micrograph of a deep hemispheric blood vessel showing replacement of vascular smooth muscle by (pink) hyaline material. There is also marked enlargement of the perivascular space. <span class=\"figcredit\">From Prayson, R: Neuropathology 1e (Churchill Livingstone 2005) with permission;</span> <a class=\"calibre5\" id=\"f9005\"></a><a class=\"calibre5\" id=\"ca9000\"></a><a class=\"calibre5\" id=\"sp9000\"></a><strong class=\"calibre8\">(B)</strong> Photograph of a coronal brain section showing multiple lacunar infarcts in the basal ganglia as a result of small vessel disease (including prominent slit-like spaces, labelled \u201cS\u201d). <span class=\"figcredit\">From Stevens and Lowe: Pathology 2e (Mosby 2000) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00265.jpeg", "image_caption": "<figcaption class=\"figleg\"><span class=\"fignum\">Fig. 12.20</span> <a class=\"calibre5\" id=\"sp0190\"></a>Post-mortem photograph of the brain in a case of frontotemporal dementia (FTD).<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0195\"></a>Macroscopic photograph showing selective degeneration of the frontal and temporal lobes. The primary sensory and motor areas are spared. <span class=\"figcredit\">From Prayson, R: Neuropathology 1e (Churchill Livingstone 2005) with permission.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00277.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0110\"></a><span class=\"fignum\">Fig. 12.21</span> <a class=\"calibre5\" id=\"sp0200\"></a>Positron emission tomography (PET) with the beta-amyloid specific radiotracer carbon-11 labelled Pittsburgh Compound B (<sup class=\"calibre14\">11</sup>C-PIB) in patients with frontotemporal dementia (FTD, top row) and Alzheimer's disease (AD, bottom row).<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0205\"></a>PIB-PET imaging in the patient with Alzheimer's disease reveals diffuse cortical binding of amyloid beta, in contrast to non-specific white matter labelling in the patient with FTD. In both cases, pathological confirmation of the diagnosis was subsequently obtained at post-mortem examination. <span class=\"figcredit\">Axial distribution volume ratio (DVR) images provided courtesy of Dr Gil Rabinovici.</span></figcaption>"}, {"image_source": "https://textbook-images-19283761293.s3.amazonaws.com/neuroscience/00278.jpeg", "image_caption": "<figcaption class=\"figleg\"><a class=\"calibre5\" id=\"ca0115\"></a><span class=\"fignum\">Fig. 12.22</span> <a class=\"calibre5\" id=\"sp0210\"></a>Neuroimaging findings in the three main variants of frontotemporal dementia (FTD).<br class=\"calibre7\"/><a class=\"calibre5\" id=\"sp0215\"></a><strong class=\"calibre8\">(A)</strong> In the behavioural variant of FTD there is usually bilateral frontal lobe atrophy which is often worse on the non-dominant side; <strong class=\"calibre8\">(B)</strong> In semantic dementia severe bilateral temporal lobe atrophy is typical; <strong class=\"calibre8\">(C)</strong> Progressive non-fluent aphasia is characterized by dominant (usually left) hemisphere atrophy in the inferior frontal gyrus and perisylvian region, corresponding to the left-hemisphere language areas. [Coronal T1-weighted MRI scans. The arrows indicate the most severely affected areas.] <span class=\"figcredit\">From Schott, JM and Fox, NC: Structural imaging in the dementias. J Psychiat (Old Age Psychiatr) (2007, pp. 503\u2013507) with permission.</span></figcaption>"}]